Skip to main content

Research Repository

Advanced Search

Natasha Cox's Outputs (5)

The Longitudinal Relationship Between Pain and Depression in People with Inflammatory Arthritis: a Narrative Review (2025)
Journal Article
Cox, N., Farooq, S., Twohig, H., & C Scott, I. (in press). The Longitudinal Relationship Between Pain and Depression in People with Inflammatory Arthritis: a Narrative Review. Arthritis Care & Research, 1-32. https://doi.org/10.1002/acr.25532

As many patients with inflammatory arthritis (IA) have chronic pain, understanding how to best assess and manage pain in IA is a priority. Co-morbid depression is prevalent in adults with IA, affecting 15 to 39% of people. Whilst pain and depression... Read More about The Longitudinal Relationship Between Pain and Depression in People with Inflammatory Arthritis: a Narrative Review.

Pharmacological pain management in patients with rheumatoid arthritis: a narrative literature review (2025)
Journal Article
Cox, N., Mallen, C. D., & Scott, I. C. (2025). Pharmacological pain management in patients with rheumatoid arthritis: a narrative literature review. BMC Medicine, 23(1), Article 54. https://doi.org/10.1186/s12916-025-03870-0

Background: Pain is a major challenge for patients with rheumatoid arthritis (RA), with many people suffering chronic pain. Current RA management guidelines focus on assessing and reducing disease activity using disease-modifying anti-rheumatic drugs... Read More about Pharmacological pain management in patients with rheumatoid arthritis: a narrative literature review.

The relationship between pain and depression and anxiety in patients with inflammatory arthritis: a systematic review protocol (2023)
Journal Article
Cox, N., Hawarden, A., Bajpai, R., Farooq, S., Twohig, H., Muller, S., & Scott, I. C. (2024). The relationship between pain and depression and anxiety in patients with inflammatory arthritis: a systematic review protocol. Rheumatology International, 44, 435–440. https://doi.org/10.1007/s00296-023-05450-y

Pain is a major challenge for patients with inflammatory arthritis (IA). Depression and anxiety are common comorbidities in IA, associating with worse outcomes. How they relate to pain is uncertain, with existing systematic reviews (a) mainly conside... Read More about The relationship between pain and depression and anxiety in patients with inflammatory arthritis: a systematic review protocol.

Effectiveness and safety of secukinumab in ankylosing spondylitis: real-life data from Midlands Ankylosing Spondylitis Collaboration (MASC) (2022)
Journal Article
Ajibade, A., Pandian, H., Jain, N., Gupta, L., Laxminarayan, R., Moorthy, A., Amarasena, R., Cox, N., Sapkota, H., Kakade, G., Elamanchi, S., Prabu, A., Al-Samaraaie, E., & Barkham, N. (2022). Effectiveness and safety of secukinumab in ankylosing spondylitis: real-life data from Midlands Ankylosing Spondylitis Collaboration (MASC). Rheumatology Advances in Practice, 7(1), https://doi.org/10.1093/rap/rkad029

The impact of the COVID-19 pandemic and stringent social distancing measures on health-related quality of life and COVID-19 infection rates in patients with rheumatic disease: a longitudinal analysis through the pandemic (2022)
Journal Article
Cox, N., R Raizada, S., Barkham, N., Venkatachalam, S., Sheeran, T. P., Adizie, T., Sapkota, H., C Scott, I., Muller, S., & Bateman, J. (2022). The impact of the COVID-19 pandemic and stringent social distancing measures on health-related quality of life and COVID-19 infection rates in patients with rheumatic disease: a longitudinal analysis through the pandemic. Rheumatology Advances in Practice, 7(1), Article rkad009. https://doi.org/10.1093/rap/rkad009

Objective The aim was to evaluate the impact of the coronavirus disease 2019 (COVID-19) pandemic and stringent social isolation measures on patients with rheumatic disease (RD) from the beginning of the pandemic (April 2020). Methods In this UK-based... Read More about The impact of the COVID-19 pandemic and stringent social distancing measures on health-related quality of life and COVID-19 infection rates in patients with rheumatic disease: a longitudinal analysis through the pandemic.